Pharmacokinetics and tissue penetration of ciprofloxacin
- 1 November 1983
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 24 (5) , 784-786
- https://doi.org/10.1128/aac.24.5.784
Abstract
A 500-mg dose of the quinoline ciprofloxacin was administered orally to each of six healthy male volunteers, after which the concentrations of this agent in serum and blister fluid were measured. Absorption appeared to be rapid, with a mean peak level of 2.4 micrograms/ml attained 1.25 h after administration. The serum elimination half-life was 3.9 h. The agent penetrated blister fluid well, the percent penetration being 57%. Urinary recovery of ciprofloxacin was 30%.This publication has 6 references indexed in Scilit:
- Norfioxacin (MK–0366) treatment of urinary tract infections in hospitalized patientsJournal of Antimicrobial Chemotherapy, 1983
- In vitro activity of ciprofloxacin, norfloxacin and nalidixic acidEuropean Journal of Clinical Microbiology & Infectious Diseases, 1983
- In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agentsAntimicrobial Agents and Chemotherapy, 1983
- Determination of norfloxacin, a new nalidixic acid analog, in human serum and urine by high-performance liquid chromatographyAntimicrobial Agents and Chemotherapy, 1982
- The Influence of Protein Binding upon Tissue Fluid Levels of Six -Lactam AntibioticsThe Journal of Infectious Diseases, 1980
- Clinical PharmacokineticsNew England Journal of Medicine, 1975